The Microfluidics team of experts was proud to exhibit at the 2024 Interphex tradeshow on April 16-18 at the Javits Center in New York City. This esteemed tradeshow is "the leading global pharmaceutical and biotechnology event that fuses industry innovation with expert-led conference. This dynamic platform unites professionals, fostering collaborations and providing a comprehensive view of advancements in pharmaceutical manufacturing, process development, and regulatory compliance."
Microfluidics was awarded the prestigious
Biotech Innovation Award on behalf of
the NEW MP350 Microlyser™ Processor
"The Biotech Innovation Award acknowledges an exhibitor’s innovative application to a given product or service that not only addresses an industry need but does so in such a way as to exceed previous standards or applications—thereby making the given process simpler, smoother, or easier to navigate."
Microfluidics was incredibly proud to accept this award for the Microlyser™ technology. This hybrid approach to cell disruption pairs Microfluidics' proprietary Interaction Chamber™ with a unique sanitary electric pumping system to create an unprecedented production scale solution.
Through the efforts of our engineering and application experts, across the globe, our dedicated teams worked tirelessly for 2 years to create a revolutionary biopharma technology which achieves maximum yields, improves product quality and delivers optimum yields in production scale cell disruption for a wide range of cells.
The Microfluidics team was very excited about launching this new product targeting production scale cell disruption for the bioprocessing community. The MP350 Microlyser™ processor utilizes brand new technology and was jointly developed by the IDEX MPT teams in India and Boston. It is a best-in-class example of partnership between the teams in these regions.
Steve Mesite, Director of Machines
“I’m very proud of the collaboration between our teams, excellent relationships were forged over many hours of meetings over the years. The product that came out is extremely well-designed and functions exactly as desired. This innovation offers a great opportunity for Microfluidics because it enables growth into biotech scale up opportunities that we didn’t have in the past.”
Dhiraj Pandit, Managing Director, MPT Asia,
“The Microlyser™ project was a great experience as the team from India & US collaborated to develop a technology which fills in a critical customer need. The way the team worked together is a great example of the Idex Difference in action.”
Daljit Singh, Sales Director, Microfluidics
I am so proud of this team for their phenomenal work in successfully developing the Microlyser™ technology. The team had displayed amazing collaboration and partnership approach in handling project’s complexities with positive mindset, which was key to success. It was an honor to be part of this great team.”
To learn more about this subject, contact us directly.
Related reading:
